Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 634,210 | 528,295 | 399,356 | 329,233 | 305,514 |
| Cost of Goods | 72,929 | 52,943 | 37,326 | 38,599 | 34,466 |
| Gross Profit | 561,281 | 475,352 | 362,030 | 290,634 | 271,048 |
| Operating Expenses | 529,421 | 451,419 | 439,567 | 503,353 | 477,948 |
| Operating Income | 32,789 | 24,876 | -77,211 | -212,120 | -206,434 |
| Interest Expense | 46,159 | 49,598 | 50,149 | 37,119 | 32,471 |
| Other Income | 13,561 | -4,034 | -22,741 | 7,200 | -2,649 |
| Pre-tax Income | 191 | -28,756 | -150,101 | -242,039 | -241,554 |
| Income Tax | 27,301 | 27,350 | 1,483 | -5,471 | 8,906 |
| Net Income Continuous | -27,110 | -56,106 | -151,584 | -236,568 | -250,460 |
| Net Income | $-27,110 | $-56,106 | $-151,584 | $-236,568 | $-250,460 |
| EPS Basic Total Ops | -0.09 | -0.18 | -0.51 | -0.82 | -0.92 |
| EPS Basic Continuous Ops | -0.09 | -0.18 | -0.51 | -0.82 | -0.92 |
| EPS Diluted Total Ops | -0.09 | -0.18 | -0.51 | -0.82 | -0.92 |
| EPS Diluted Continuous Ops | -0.09 | -0.18 | -0.51 | -0.82 | -0.92 |
| EPS Diluted Before Non-Recurring Items | 0.03 | -0.04 | -0.51 | -0.82 | -0.92 |
| EBITDA(a) | $42,819 | $35,685 | $-66,722 | $-204,144 | $-197,735 |